课题基金 / 基金详情

DEVELOPMENT OF NEW DENTAL COMPOSITE FORMULATIONS

DEVELOPMENT OF NEW DENTAL COMPOSITE FORMULATIONS
新型牙科复合材料配方的开发
批准号:
2131115
负责人:
SID KALACHANDRA
金额:
$16.65万
依托单位国家:
美国
项目类别:
财政年份:
1994
资助国家:
美国
项目状态:
已结题
起止时间:
1994-02-01 至 1997-01-31

项目摘要

项目成果

SID KALACHANDRA的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The long range goal of this study is the development of dental composites which are less technique sensitive, wet tooth structure more readily, and have reduced curing shrinkage and water sorption. Composites have several advantages over available alternative materials: direct technique, esthetic appearance, and adhesion to tooth structure. Even so, remaining problems limit their increased use in posterior applications, where dental amalgams are still used in three-fourths of all restorations. Two major problems are stresses in the tooth created by uncompensated curing shrinkage, and the necessity of isolating current materials from moisture during placement, which requires the use of demanding and unpopular clinical procedures. The urgency of solving these problems is increased by the possibility that dental amalgam, (the only alternative direct material), may be banned because of mercury hazards. This study proposes to prepare and evaluate the series of composite materials based upon newly synthesized matrix monomers. The work is based upon the hypothesis that the problems with current materials are largely due to the quantity of diluent monomers required to control matrix viscosity, and therefore that the use of matrix monomers of lower viscosity would lead to improved properties. Recent pilot work in this laboratory has confirmed this hypothesis. Modifications of the traditional BIS-GMA monomer will be prepared, as well as two series of monomers in which the central -C(CH3)2- is replaced by groups containing phosphorous or fluorine. In each series three monomers will be prepared. One with pendant -OH group characteristic of BIS-GMA, and others with the -OH replaced by -H and -CH3. Synthesis schemes and conditions will be adjusted to avoid hydrogen bonding and oligomerization, thus minimizing viscosity. Where the viscosity of the pure monomer exceeds the viscosity characteristic of present uncured matrix materials, it will be diluted with TEGDM as needed to produce a standard viscosity. Each material will be evaluated as a monomer, as the unfilled polymer and as the matrix of a hybrid composite. The monomers will be tested for viscosity, wetting ability, water sorption and curing shrinkage. The polymers and composites will be tested for water sorption, we ability by water and saliva, and a series of physical and mechanical properties.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CLINICAL TRIAL: CLINICAL TRIALS OF 25% CHLORHEXIDINE DIACETATE INTRAORAL DELIVER
Intra-oral Drug Delivery Systems for HIV/AIDS Patients
Intra-oral Drug Delivery Systems for HIV/AIDS Patients
Intra-oral Drug Delivery Systems for HIV/AIDS Patients